10-[3-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)benzene-2-id-1-yl]-2-(3,5-dimethylpyrazol-1-yl)-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-5-methyl-10-[3-[phenyl(pyridin-2-yl)methyl]benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(1-pyridin-2-ylcyclohexyl)benzene-2-id-1-yl]-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(5-pyridin-2-ylnonan-5-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;pentakis(platinum(2+))

C200H175N21O2Pt5S2 — CID 158608117

About 10-[3-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)benzene-2-id-1-yl]-2-(3,5-dimethylpyrazol-1-yl)-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-5-methyl-10-[3-[phenyl(pyridin-2-yl)methyl]benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(1-pyridin-2-ylcyclohexyl)benzene-2-id-1-yl]-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(5-pyridin-2-ylnonan-5-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;pentakis(platinum(2+))

10-[3-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)benzene-2-id-1-yl]-2-(3,5-dimethylpyrazol-1-yl)-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-5-methyl-10-[3-[phenyl(pyridin-2-yl)methyl]benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(1-pyridin-2-ylcyclohexyl)benzene-2-id-1-yl]-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(5-pyridin-2-ylnonan-5-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;pentakis(platinum(2+)) (PubChem CID 158608117) has the molecular formula C200H175N21O2Pt5S2 and a molecular weight of 3944.27 g/mol. Its IUPAC name is 10-[3-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)benzene-2-id-1-yl]-2-(3,5-dimethylpyrazol-1-yl)-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-5-methyl-10-[3-[phenyl(pyridin-2-yl)methyl]benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(1-pyridin-2-ylcyclohexyl)benzene-2-id-1-yl]-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(5-pyridin-2-ylnonan-5-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;pentakis(platinum(2+)).

Molecular Properties

• Compound Name: 10-[3-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)benzene-2-id-1-yl]-2-(3,5-dimethylpyrazol-1-yl)-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-5-methyl-10-[3-[phenyl(pyridin-2-yl)methyl]benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(1-pyridin-2-ylcyclohexyl)benzene-2-id-1-yl]-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(5-pyridin-2-ylnonan-5-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;pentakis(platinum(2+))
• PubChem CID: 158608117
• Molecular Formula: C200H175N21O2Pt5S2
• Molecular Weight: 3944.27 g/mol
• Exact Mass: 3941.19
• IUPAC Name: 10-[3-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)benzene-2-id-1-yl]-2-(3,5-dimethylpyrazol-1-yl)-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-5-methyl-10-[3-[phenyl(pyridin-2-yl)methyl]benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(1-pyridin-2-ylcyclohexyl)benzene-2-id-1-yl]-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(5-pyridin-2-ylnonan-5-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;pentakis(platinum(2+))
• SMILES: CCCCC(CCCC)(c1[c-]c(N2c3[c-]c(-n4nc(C)cc4C)ccc3Oc3ccccc32)ccc1)c1ccccn1.Cc1cc(C)n(-c2[c-]c3c(cc2)N(C)c2ccccc2N3c2[c-]c(C(c3ccccc3)c3ccccn3)ccc2)n1.Cc1cc(C)n(-c2[c-]c3c(cc2)Oc2ccccc2N3c2[c-]c(C3(c4ccccn4)c4ccccc4C(C)(C)c4ccccc43)ccc2)n1.Cc1cc(C)n(-c2[c-]c3c(cc2)Sc2ccccc2N3c2[c-]c(C3(c4ccccn4)CCCCC3)ccc2)n1.Cc1cc(C)n(-c2[c-]c3c(cc2)Sc2ccccc2N3c2[c-]c(C3(c4ccccn4)c4cc(C(C)(C)C)ccc4-c4ccc(C(C)(C)C)cc43)ccc2)n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2]
• InChI: InChI=1S/C49H44N4S.C44H34N4O.C37H38N4O.C36H29N5.C34H30N4S.5Pt/c1-31-26-32(2)53(51-31)37-21-24-45-43(30-37)52(42-16-9-10-17-44(42)54-45)36-15-13-14-35(27-36)49(46-18-11-12-25-50-46)40-28-33(47(3,4)5)19-22-38(40)39-23-20-34(29-41(39)49)48(6,7)8;1-29-26-30(2)48(46-29)33-23-24-41-39(28-33)47(38-20-9-10-21-40(38)49-41)32-15-13-14-31(27-32)44(42-22-11-12-25-45-42)36-18-7-5-16-34(36)43(3,4)35-17-6-8-19-37(35)44;1-5-7-21-37(22-8-6-2,36-18-11-12-23-38-36)29-14-13-15-30(25-29)40-32-16-9-10-17-34(32)42-35-20-19-31(26-33(35)40)41-28(4)24-27(3)39-41;1-25-22-26(2)41(38-25)30-19-20-33-35(24-30)40(34-18-8-7-17-32(34)39(33)3)29-15-11-14-28(23-29)36(27-12-5-4-6-13-27)31-16-9-10-21-37-31;1-24-21-25(2)38(36-24)28-16-17-32-30(23-28)37(29-13-4-5-14-31(29)39-32)27-12-10-11-26(22-27)34(18-7-3-8-19-34)33-15-6-9-20-35-33;;;;;/h9-26,28-29H,1-8H3;5-26H,1-4H3;9-20,23-24H,5-8,21-22H2,1-4H3;4-22,36H,1-3H3;4-6,9-17,20-21H,3,7-8,18-19H2,1-2H3;;;;;/q5*-2;5*+2
• InChIKey: TXMUCRIZMWMHCE-UHFFFAOYSA-N
• XLogP: 49.06
• TPSA: 191.45 Ų
• H-Bond Acceptors: 25
• Rotatable Bonds: 27
• Heavy Atoms: 230
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3944.27
LogP ≤ 5	49.06
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	25

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 10-[3-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)benzene-2-id-1-yl]-2-(3,5-dimethylpyrazol-1-yl)-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-5-methyl-10-[3-[phenyl(pyridin-2-yl)methyl]benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(1-pyridin-2-ylcyclohexyl)benzene-2-id-1-yl]-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(5-pyridin-2-ylnonan-5-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;pentakis(platinum(2+))?

The IUPAC name of 10-[3-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)benzene-2-id-1-yl]-2-(3,5-dimethylpyrazol-1-yl)-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-5-methyl-10-[3-[phenyl(pyridin-2-yl)methyl]benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(1-pyridin-2-ylcyclohexyl)benzene-2-id-1-yl]-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(5-pyridin-2-ylnonan-5-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;pentakis(platinum(2+)) (CID 158608117) is 10-[3-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)benzene-2-id-1-yl]-2-(3,5-dimethylpyrazol-1-yl)-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-5-methyl-10-[3-[phenyl(pyridin-2-yl)methyl]benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(1-pyridin-2-ylcyclohexyl)benzene-2-id-1-yl]-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(5-pyridin-2-ylnonan-5-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;pentakis(platinum(2+)).

What is the SMILES notation for 10-[3-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)benzene-2-id-1-yl]-2-(3,5-dimethylpyrazol-1-yl)-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-5-methyl-10-[3-[phenyl(pyridin-2-yl)methyl]benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(1-pyridin-2-ylcyclohexyl)benzene-2-id-1-yl]-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(5-pyridin-2-ylnonan-5-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;pentakis(platinum(2+))?

The canonical SMILES for 10-[3-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)benzene-2-id-1-yl]-2-(3,5-dimethylpyrazol-1-yl)-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-5-methyl-10-[3-[phenyl(pyridin-2-yl)methyl]benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(1-pyridin-2-ylcyclohexyl)benzene-2-id-1-yl]-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(5-pyridin-2-ylnonan-5-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;pentakis(platinum(2+)) is CCCCC(CCCC)(c1[c-]c(N2c3[c-]c(-n4nc(C)cc4C)ccc3Oc3ccccc32)ccc1)c1ccccn1.Cc1cc(C)n(-c2[c-]c3c(cc2)N(C)c2ccccc2N3c2[c-]c(C(c3ccccc3)c3ccccn3)ccc2)n1.Cc1cc(C)n(-c2[c-]c3c(cc2)Oc2ccccc2N3c2[c-]c(C3(c4ccccn4)c4ccccc4C(C)(C)c4ccccc43)ccc2)n1.Cc1cc(C)n(-c2[c-]c3c(cc2)Sc2ccccc2N3c2[c-]c(C3(c4ccccn4)CCCCC3)ccc2)n1.Cc1cc(C)n(-c2[c-]c3c(cc2)Sc2ccccc2N3c2[c-]c(C3(c4ccccn4)c4cc(C(C)(C)C)ccc4-c4ccc(C(C)(C)C)cc43)ccc2)n1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt+2].

What is the InChIKey of 10-[3-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)benzene-2-id-1-yl]-2-(3,5-dimethylpyrazol-1-yl)-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-5-methyl-10-[3-[phenyl(pyridin-2-yl)methyl]benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(1-pyridin-2-ylcyclohexyl)benzene-2-id-1-yl]-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(5-pyridin-2-ylnonan-5-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;pentakis(platinum(2+))?

The InChIKey is TXMUCRIZMWMHCE-UHFFFAOYSA-N. The full InChI is InChI=1S/C49H44N4S.C44H34N4O.C37H38N4O.C36H29N5.C34H30N4S.5Pt/c1-31-26-32(2)53(51-31)37-21-24-45-43(30-37)52(42-16-9-10-17-44(42)54-45)36-15-13-14-35(27-36)49(46-18-11-12-25-50-46)40-28-33(47(3,4)5)19-22-38(40)39-23-20-34(29-41(39)49)48(6,7)8;1-29-26-30(2)48(46-29)33-23-24-41-39(28-33)47(38-20-9-10-21-40(38)49-41)32-15-13-14-31(27-32)44(42-22-11-12-25-45-42)36-18-7-5-16-34(36)43(3,4)35-17-6-8-19-37(35)44;1-5-7-21-37(22-8-6-2,36-18-11-12-23-38-36)29-14-13-15-30(25-29)40-32-16-9-10-17-34(32)42-35-20-19-31(26-33(35)40)41-28(4)24-27(3)39-41;1-25-22-26(2)41(38-25)30-19-20-33-35(24-30)40(34-18-8-7-17-32(34)39(33)3)29-15-11-14-28(23-29)36(27-12-5-4-6-13-27)31-16-9-10-21-37-31;1-24-21-25(2)38(36-24)28-16-17-32-30(23-28)37(29-13-4-5-14-31(29)39-32)27-12-10-11-26(22-27)34(18-7-3-8-19-34)33-15-6-9-20-35-33;;;;;/h9-26,28-29H,1-8H3;5-26H,1-4H3;9-20,23-24H,5-8,21-22H2,1-4H3;4-22,36H,1-3H3;4-6,9-17,20-21H,3,7-8,18-19H2,1-2H3;;;;;/q5*-2;5*+2.

What are the key properties of 10-[3-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)benzene-2-id-1-yl]-2-(3,5-dimethylpyrazol-1-yl)-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-5-methyl-10-[3-[phenyl(pyridin-2-yl)methyl]benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(1-pyridin-2-ylcyclohexyl)benzene-2-id-1-yl]-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(5-pyridin-2-ylnonan-5-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;pentakis(platinum(2+))?

10-[3-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)benzene-2-id-1-yl]-2-(3,5-dimethylpyrazol-1-yl)-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-5-methyl-10-[3-[phenyl(pyridin-2-yl)methyl]benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(1-pyridin-2-ylcyclohexyl)benzene-2-id-1-yl]-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(5-pyridin-2-ylnonan-5-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;pentakis(platinum(2+)) has a molecular weight of 3944.27 g/mol, XLogP of 49.06, 27 rotatable bonds, 0 hydrogen bond donors, and 25 hydrogen bond acceptors.

Where does this data come from?

All data for 10-[3-(2,7-ditert-butyl-9-pyridin-2-ylfluoren-9-yl)benzene-2-id-1-yl]-2-(3,5-dimethylpyrazol-1-yl)-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(10,10-dimethyl-9-pyridin-2-ylanthracen-9-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-5-methyl-10-[3-[phenyl(pyridin-2-yl)methyl]benzene-2-id-1-yl]-1H-phenazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(1-pyridin-2-ylcyclohexyl)benzene-2-id-1-yl]-1H-phenothiazin-1-ide;2-(3,5-dimethylpyrazol-1-yl)-10-[3-(5-pyridin-2-ylnonan-5-yl)benzene-2-id-1-yl]-1H-phenoxazin-1-ide;pentakis(platinum(2+)) is sourced from PubChem (CID 158608117), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).